ClinicalTrials.gg
Drug

Axatilimab clinical trials

Also written SNDX-6352 and INCA034176.

studies test it
26
open now
14
in phase 3
3
first study started
2017

How each study uses axatilimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the axatilimab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Aug 2024 · NIKTIMVO · BLA 761411 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Axatilimab
24
Niktimvo
4
Anti-M-CSFR Monoclonal Antibody SNDX-6352
2
Axatilimab (SNDX-6352)
2

Development codes

SNDX-6352
8
INCA034176
5
UCB6352
2
SNDX6532
1

Studies by the year they started

25 studies that test it; most in 2025 (7); 1 more planned to start later

Studies that test axatilimab, by start year
YearStudies
20171
20181
20201
20211
20233
20245
20257
20266

Who runs them

Industry 12 · Other 14

Incyte Corporation (6) · Syndax Pharmaceuticals (5) · Northside Hospital, Inc. (2) · Stephen Shiao (2) · M.D. Anderson Cancer Center (2) · Incyte Biosciences Japan GK (1) · University of Utah (1) · Medical College of Wisconsin (1)

Often tested with

Tested in the same studies.

Ruxolitinib (2) · Adrenal Cortex Hormones (1) · Decitabine (1) · Venetoclax (1) · Cyclophosphamide (1) · Retifanlimab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7, 1 in phase 3

Studies that test axatilimab, phase 3 first.

Studies

Open first, then newest update. How each study uses axatilimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test axatilimab →

Given beside what is tested · 1 — axatilimab is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call axatilimab · ClinicalTrials.gg INT001459

  • MeSH (NLM) C000711669axatilimabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) R96Z451BMCAXATILIMABConfirmed FDA, NLM
  • NCI Thesaurus C155813AxatilimabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.